Cor Vasa 2010, 52(7-8):397-398 | DOI: 10.33678/cor.2010.107
Tachycardia-induced cardiomyopathy
- Kardiologické oddělení, Kardiovaskulární centrum, Fakultní nemocnice Motol, Praha, Česká republika
Tachycardia-induced cardiomyopathy is characterized by the presence of systolic ventricular dysfunction and dilatation with clinical presentation of heart failure in patients with chronic tachyarrhythmias. A typical feature of the disease is partial or full reversibility of functional and structural alterations upon adequate therapy. A practical approach to the management of the tachycardia-induced cardiomyopathy includes 1) control of the tachyarrhythmia as the main pathophysiological factor behind the development and progression of the disease, and 2) management of heart failure. Most importantly, every effort should be made to restore a normal heart rate.
Keywords: Cardiomyopathy; Tachycardia; Heart failure
Published: July 1, 2010 Show citation
References
- Umana E, Solares A, Alpert MA. Tachycardia-induced cardiomyopathy. Review. Am J Med 2003;114:51-55.
Go to original source...
Go to PubMed...
- Khasnis A, Jongnarangsin K, Abela G, et al. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol 2005;28:710-721.
Go to original source...
Go to PubMed...
- Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-715.
Go to original source...
Go to PubMed...
- Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004;110:1-5.
Go to original source...
Go to PubMed...